Robin E Ferner

Jul 21, 2023 | bpspubs.onlinelibrary.wiley.com | Andrew Barron |Jennifer Chung |Robin E Ferner

CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare. REFERENCES 1 European Medicines Agency. Biosimilar medicines: overview. Accessed November 13, 2022. https://www.ema.europa.eu/en/human-regulatory/overview/biosimilar-medicines-overview 2 NHS England, NHS Improvement, NHS Clinical Commissioners. Commissioning framework for biological medicines (including biosimilar medicines). Version 1. Gateway reference: 06924. Published online September 2017.

Jul 16, 2023 | bpspubs.onlinelibrary.wiley.com | Jeffrey K Aronson |Carl Heneghan |Robin E Ferner

1 INTRODUCTION In the first part of this two-part review on drug shortages, we discussed how drug shortages are defined and the harms, including medication errors, that can result. In this second part, we shall discuss the trends in drug shortages, their causes and potential solutions.

Jul 16, 2023 | bpspubs.onlinelibrary.wiley.com | Jeffrey K Aronson |Carl Heneghan |Robin E Ferner

1 INTRODUCTION Drug shortages are often in the news1 and are often looked on as a recent phenomenon. However, drug shortages have been with us for a long time.